Navigation Links
Professor Nancy Ip Joins aTyr Pharma's Scientific Advisory Board
Date:8/17/2009

SAN DIEGO, Aug. 17 /PRNewswire/ -- aTyr Pharma announced today that Professor Nancy Ip, Chair Professor of the Department of Biochemistry and Director of the Molecular Neuroscience Center at Hong Kong University of Science and Technology (HKUST), has joined their scientific advisory board. An elected academician of the Chinese Academy of Sciences and recipient of China's highest honor in the natural sciences, the National Natural Sciences award, Prof. Ip is widely respected for her discoveries in neurosciences. Her accomplishments include elucidation of key signaling mechanisms for nerve cells that have resulted in the discovery of potential treatments for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.

aTyr Pharma has discovery candidates for treatment of neurological disorders as well as other indications. These novel, naturally occurring proteins are resectins of tRNA synthetases. According to Jeff Watkins, CEO of aTyr Pharma, "The tRNA synthetases play a fundamental role in protein synthesis, but tRNA synthetases in humans have resected forms ("resectins") which provide additional essential signaling activities. aTyr Pharma has discovered proprietary resectins with neuro-protective activities. Applying Prof. Ip's knowledge and experience in neurosciences will accelerate our understanding and development of aTyr Pharma's novel class of therapeutic proteins, helping us to bring novel treatments for neuronal diseases to the market as quickly as possible."

Professor Paul Schimmel of TSRI and co-founder of aTyr Pharma adds, "Prof. Ip has established a world renowned Center for Molecular Neurosciences at HKUST focused on discovery of new medicines, and we look forward to using her perspectives for understanding the neurobiology of our resectins. In addition to her remarkable discoveries in neuroscience, Prof. Ip brings a passion for promoting science and biotechnology in China and Hong Kong. With Pangu BioPharma, our subsidiary based in Hong Kong, we share Prof. Ip's goal of tapping the scientific talents and resources in China for strategic advantages in the biotechnology arena."

Prof. Ip obtained her Ph. D. in Pharmacology from Harvard Medical School before working as a senior staff scientist of Regeneron Pharmaceuticals, Inc. in New York and ultimately joining HKUST. She has published more than 200 papers with over 13,000 citations by other scientists and holds 18 patents. Editor-in-Chief of NeuroSignals, Prof. Ip also sits on the editorial boards for several international journals including Journal of Neuroscience. Her extensive list of awards includes being the first honoree in life sciences from China for the L'Oreal-UNESCO Women in Science Award, and being awarded the Scientific and Technological Prize of the Ho Leung Ho Lee Foundation. She received an honorary Doctor of Humane Sciences degree from Simmons College, as well as the Leader of the Year award in research and the Medal of Honor from the Hong Kong Government.

About aTyr Pharma

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery of an entirely new class of biologics. aTyr Pharma's discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These proteins are being developed as novel therapeutics to treat cancer, neurodegenerative diseases, inflammation, cardiovascular diseases and metabolic disorders.

www.atyrpharma.com


'/>"/>
SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Physics professor lauded for NSF efforts with prestigious award
2. Physics professor lauded for NSF efforts with prestigious award
3. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
4. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
5. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
6. Cambridge Major Appoints Professor John Hartwig as Scientific Advisor
7. Professor Straufs research is Nature Photonics’ cover article
8. Professor Toh-Ming Lu named fellow of the Materials Research Society
9. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
10. Professor-turned-producer learns the movie biz
11. UCF professor develops vaccine to protect against black plague bioterror attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
(Date:10/11/2017)... ... 11, 2017 , ... A new study published in Fertility ... fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort ... After comparing the results from the fresh and frozen transfer cohorts, the authors ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):